Detalles de la búsqueda
1.
The impact of the histological classification of ampullary carcinomas on long-term outcomes after pancreaticoduodenectomy: a single tertiary referral center evaluation.
Langenbecks Arch Surg
; 407(7): 2811-2821, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-35670860
2.
Focus on RAS Codon 61 Mutations in Metastatic Colorectal Cancer: A Retrospective Analysis.
Cancers (Basel)
; 16(5)2024 Feb 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38473349
3.
Pemigatinib for patients with previously treated, locally advanced or metastatic cholangiocarcinoma harboring FGFR2 fusions or rearrangements: A joint analysis of the French PEMI-BIL and Italian PEMI-REAL cohort studies.
Eur J Cancer
; 200: 113587, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38340384
4.
The role of the multidisciplinary tumor board (MDTB) in the assessment of pancreatic cancer diagnosis and resectability: A tertiary referral center experience.
Front Surg
; 10: 1119557, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36874464
5.
Efficacy of third-line anti-EGFR-based treatment versus regorafenib or trifluridine/tipiracil according to primary tumor site in RAS/BRAF wild-type metastatic colorectal cancer patients.
Front Oncol
; 13: 1125013, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36895480
6.
An Immune-Related Gene Expression Signature Predicts Benefit from Adding Atezolizumab to FOLFOXIRI plus Bevacizumab in Metastatic Colorectal Cancer.
Clin Cancer Res
; 29(12): 2291-2298, 2023 06 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-37022350
7.
Management of single pulmonary metastases from colorectal cancer: State of the art.
World J Gastrointest Oncol
; 14(4): 820-832, 2022 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35582100
8.
Role of Chemoradiation in the Adjuvant Treatment of Radically Resected Pancreatic Cancer Patients: A Mono-Institutional Retrospective Analysis.
Oncol Res Treat
; 45(10): 588-597, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35882183
9.
Primary versus secondary antiemetic prophylaxis with NK1 receptor antagonists in patients affected by gastrointestinal malignancies and treated with a doublet or triplet combination regimen including oxaliplatin and/or irinotecan plus fluoropyrimidines: A propensity score matched analysis.
Front Oncol
; 12: 935826, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36033477
10.
Clinical, Pathological and Prognostic Features of Rare BRAF Mutations in Metastatic Colorectal Cancer (mCRC): A Bi-Institutional Retrospective Analysis (REBUS Study).
Cancers (Basel)
; 13(9)2021 Apr 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-33925278
11.
KRAS G12C Metastatic Colorectal Cancer: Specific Features of a New Emerging Target Population.
Clin Colorectal Cancer
; 19(3): 219-225, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32605718
12.
Retreatment With Anti-EGFR Antibodies in Metastatic Colorectal Cancer Patients: A Multi-institutional Analysis.
Clin Colorectal Cancer
; 19(3): 191-199.e6, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32466976
13.
PTEN in Colorectal Cancer: Shedding Light on Its Role as Predictor and Target.
Cancers (Basel)
; 11(11)2019 Nov 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31717544
14.
Conversion Therapy With Encorafenib and Cetuximab for Chemo-Refractory BRAF V600E-Mutated Liver-Limited Colorectal Cancer Metastasis: The First Case Report.
Clin Colorectal Cancer
; 20(4): 364-367, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34629317
Resultados
1 -
14
de 14
1
Próxima >
>>